BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21233067)

  • 1. A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.
    Deschamps L; Signate A; Delaunay C; Morales I; Warter A; Smadja D; Derancourt C
    Eur J Dermatol; 2011; 21(1):114-5. PubMed ID: 21233067
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravascular B-cell lymphoma: the role of skin biopsy.
    Barnett CR; Seo S; Husain S; Grossman ME
    Am J Dermatopathol; 2008 Jun; 30(3):295-9. PubMed ID: 18496438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1-positive diffuse large B-cell lymphoma.
    Rodriguez-Justo M; Huang Y; Ye H; Liu H; Chuang SS; Munson P; Prada-Puentes C; Kim I; Du MQ; Bacon CM
    Histopathology; 2008 Jun; 52(7):900-3. PubMed ID: 18494615
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Richter syndrome: report of a case].
    Chen DB; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):487-8. PubMed ID: 21055184
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma with germinal center B-cell phenotype mimicking primary effusion lymphoma.
    Lim Y; Kim TY; Choi IS; Kim BS; Lee TS; Kim JE; Chang MS; Kim KH
    J Clin Oncol; 2011 Apr; 29(10):e271-3. PubMed ID: 21220599
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
    Kagoya Y; Takahashi T; Yoshimoto T; Ichikawa M; Hangaishi A; Fukayama M; Kurokawa M
    Ann Hematol; 2011 Feb; 90(2):219-20. PubMed ID: 20432036
    [No Abstract]   [Full Text] [Related]  

  • 8. Testicular lymphoma.
    Thomas LC; Adonizio C; Filicko-O'Hara J; Golshayan AR; Costa LJ; Morris GJ
    Semin Oncol; 2010 Dec; 37(6):549-54. PubMed ID: 21167372
    [No Abstract]   [Full Text] [Related]  

  • 9. The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab.
    Meyer PN; Fu K; Greiner T; Smith L; Delabie J; Gascoyne R; Ott G; Rosenwald A; Braziel R; Campo E; Vose J; Lenz G; Staudt L; Chan W; Weisenburger DD
    Am J Clin Pathol; 2011 Jan; 135(1):54-61. PubMed ID: 21173124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
    Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous plasmablastic lymphoma.
    Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
    J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
    Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
    Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHOP plus rituximab--balancing facts and opinion.
    Cheson BD
    N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
    Chen DB; Wang Y; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):635-6. PubMed ID: 21092597
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
    Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrophage colony-stimulating factor produced by diffuse large B-cell lymphoma.
    Nakayama-Ichiyama S; Yokote T; Oka S; Takubo T; Tsuji M; Hanafusa T
    Br J Haematol; 2010 May; 149(3):310. PubMed ID: 20085576
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case report of composite lymphoma].
    Wu J; Wang ZC; Chen XD
    Ai Zheng; 2007 Apr; 26(4):447. PubMed ID: 17430672
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
    Furman RR; Martin P; Ruan J; Cheung YK; Vose JM; LaCasce AS; Elstrom R; Coleman M; Leonard JP
    Cancer; 2010 Dec; 116(23):5432-9. PubMed ID: 20665890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
    N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival lymphoma in a child.
    Waisbourd M; Leibovitch I; Sayar D; Elhasid R
    Cornea; 2011 May; 30(5):598-9. PubMed ID: 21107252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.